Analysis of Neglected Tropical Disease Drug and Vaccine Development Pipelines to Predict Issuance of FDA Priority Review Vouchers over the Next Decade-Reference-Cited by-同舟云学术

Analysis of Neglected Tropical Disease Drug and Vaccine Development Pipelines to Predict Issuance of FDA Priority Review Vouchers over the Next Decade

Published:2012-10-25 Issue:10 Volume:6 Page:e1803
ISSN:1935-2735
Container-title:PLoS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Stefanakis Rianna,Robertson Andrew S.,Ponder Elizabeth L.,Moree Melinda

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference24 articles.

1. Control of neglected tropical diseases;P Hotez;N Engl J Med,2007

2. Global Framework on essential health R&D;P Chirac;Lancet,2006

3. US Food and Drug Administration (FDA) (2008) FDA draft guidance for industry: tropical disease priority review vouchers. Washington (D.C.): Government Printing Office. October 2008.

4. Priority Review to Encourage Treatments for Tropical Diseases. Title 21, U.S. Code, Pts. 360n, 2007 ed. Available: http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FoodandDrugAdministrationAmendmentsActof2007/FullTextofFDAAALaw/default.htm. Accessed 4 January 2012.

5. Developing drugs for developing countries;D Ridley;Health Affairs,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Interventions for Countering Leishmaniasis and Chagas’s Disease: From Traditional Sources to Nanotechnological Systems;Pathogens;2019-08-01

2. IP-Based Incentives Against Antimicrobial Crisis: A European Perspective;IIC - International Review of Intellectual Property and Competition Law;2019-01

3. Expansion of the Priority Review Voucher Program Under the 21st Century Cures Act: Implications for Innovation and Public Health;American Journal of Law & Medicine;2018-05

4. Synthesis and in vitro evaluation of Ca 2+ channel blockers 1,4-dihydropyridines analogues against Trypanosoma cruzi and Leishmania amazonensis : SAR analysis;Parasitology International;2017-12

5. The Commercial Market For Priority Review Vouchers;Health Affairs;2016-05